JP2021507895A5 - - Google Patents
Info
- Publication number
- JP2021507895A5 JP2021507895A5 JP2020533674A JP2020533674A JP2021507895A5 JP 2021507895 A5 JP2021507895 A5 JP 2021507895A5 JP 2020533674 A JP2020533674 A JP 2020533674A JP 2020533674 A JP2020533674 A JP 2020533674A JP 2021507895 A5 JP2021507895 A5 JP 2021507895A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- oxy
- amino
- pyrazole
- cyclohexane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762607541P | 2017-12-19 | 2017-12-19 | |
| US62/607,541 | 2017-12-19 | ||
| PCT/US2018/066110 WO2019126085A1 (en) | 2017-12-19 | 2018-12-18 | Pyrazole n-linked carbamoyl cyclohexyl acids as lpa antagonists |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021507895A JP2021507895A (ja) | 2021-02-25 |
| JP2021507895A5 true JP2021507895A5 (https=) | 2022-02-01 |
| JP7301839B2 JP7301839B2 (ja) | 2023-07-03 |
Family
ID=65003575
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020533674A Active JP7301839B2 (ja) | 2017-12-19 | 2018-12-18 | Ｌｐａアンタゴニストとしてのピラゾールｎ－連結のカルバモイルシクロヘキシル酸 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US11384067B2 (https=) |
| EP (1) | EP3728216B1 (https=) |
| JP (1) | JP7301839B2 (https=) |
| KR (1) | KR102698386B1 (https=) |
| CN (1) | CN111699180B (https=) |
| AU (1) | AU2018388482A1 (https=) |
| BR (1) | BR112020011953A2 (https=) |
| CA (1) | CA3085347A1 (https=) |
| EA (1) | EA202091500A1 (https=) |
| ES (1) | ES2962367T3 (https=) |
| IL (1) | IL275361A (https=) |
| MX (1) | MX2020005874A (https=) |
| SG (1) | SG11202005701VA (https=) |
| WO (1) | WO2019126085A1 (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR108838A1 (es) | 2016-06-21 | 2018-10-03 | Bristol Myers Squibb Co | Ácidos de carbamoiloximetil triazol ciclohexilo como antagonistas de lpa |
| US11447475B2 (en) * | 2017-12-19 | 2022-09-20 | Bristol-Myers Squibb Company | Isoxazole N-linked carbamoyl cyclohexyl acids as LPA antagonists |
| ES2898364T3 (es) | 2017-12-19 | 2022-03-07 | Bristol Myers Squibb Co | Acidos carbamoilciclohexílicos ligados a N triazol como antagonistas de LPA |
| EP3853232B1 (en) | 2018-09-18 | 2023-03-01 | Bristol-Myers Squibb Company | Oxabicyclo acids as lpa antagonists |
| ES2946657T3 (es) | 2018-09-18 | 2023-07-24 | Bristol Myers Squibb Co | Acidos ciclopentílicos como antagonistas de LPA |
| CN111434655A (zh) | 2019-01-15 | 2020-07-21 | 武汉朗来科技发展有限公司 | 溶血磷脂酸受体拮抗剂及其制备方法 |
| EP4058144A1 (en) | 2019-11-15 | 2022-09-21 | Gilead Sciences, Inc. | Triazole carbamate pyridyl sulfonamides as lpa receptor antagonists and uses thereof |
| EP4161936A1 (en) | 2020-06-03 | 2023-04-12 | Gilead Sciences, Inc. | Lpa receptor antagonists and uses thereof |
| TWI843503B (zh) | 2020-06-03 | 2024-05-21 | 美商基利科學股份有限公司 | Lpa受體拮抗劑及其用途 |
| CN114456157A (zh) * | 2020-11-10 | 2022-05-10 | 武汉人福创新药物研发中心有限公司 | 氮取代氨基碳酸酯噻吩类化合物及其用途 |
| WO2022174882A1 (en) * | 2021-02-16 | 2022-08-25 | Chiesi Farmaceutici S.P.A. | 5-membered heterocyclyl carbamate derivatives as dual lpa receptor 1 and lpa receptor 2 inhibitors |
| WO2022240879A1 (en) * | 2021-05-11 | 2022-11-17 | Gilead Sciences, Inc. | Lpa receptor antagonists and uses thereof |
| KR20240007233A (ko) | 2021-05-13 | 2024-01-16 | 길리애드 사이언시즈, 인코포레이티드 | Lpa 수용체 길항제 및 이의 용도 |
| WO2023107938A1 (en) | 2021-12-08 | 2023-06-15 | Gilead Sciences, Inc. | Lpa receptor antagonists and uses thereof |
| TW202342017A (zh) | 2022-02-25 | 2023-11-01 | 美商洛子峰生物有限公司 | 用於治療與ｌｐａ受體活性相關的病狀的化合物及組合物 |
| WO2025051266A1 (zh) * | 2023-09-08 | 2025-03-13 | 西藏海思科制药有限公司 | 杂芳环衍生物的lpar1拮抗剂及其用途 |
| CN117024409A (zh) * | 2023-10-10 | 2023-11-10 | 药康众拓(北京)医药科技有限公司 | 氘代lpa1抑制剂化合物及其用途 |
| WO2026061483A1 (zh) * | 2024-09-19 | 2026-03-26 | 西藏海思科制药有限公司 | 一种lpar1拮抗剂及其用途 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002062389A1 (en) | 2001-02-08 | 2002-08-15 | Ono Pharmaceutical Co., Ltd. | Remedies for urinary diseases comprising lpa receptor controlling agents |
| US7432271B2 (en) | 2003-09-02 | 2008-10-07 | Bristol-Myers Squibb Company | Pyrazolyl inhibitors of 15-lipoxygenase |
| DE102004038403B4 (de) | 2004-08-07 | 2006-08-31 | Sanofi-Aventis Deutschland Gmbh | Verfahren zur Herstellung der enantiomeren Formen von cis-konfigurierten 3-Hydroxycyclohexancarbonsäure-Derivaten |
| CN102574822A (zh) | 2009-08-04 | 2012-07-11 | 阿米拉制药公司 | 作为溶血磷脂酸受体拮抗剂的化合物 |
| GB2474748B (en) | 2009-10-01 | 2011-10-12 | Amira Pharmaceuticals Inc | Polycyclic compounds as lysophosphatidic acid receptor antagonists |
| GB2474120B (en) | 2009-10-01 | 2011-12-21 | Amira Pharmaceuticals Inc | Compounds as Lysophosphatidic acid receptor antagonists |
| KR20130126659A (ko) | 2010-12-07 | 2013-11-20 | 아미라 파마슈티칼스 인코포레이티드 | 리소포스파티드산 수용체 길항제 및 섬유증 치료에서의 그의 용도 |
| US8785442B2 (en) | 2011-01-30 | 2014-07-22 | Curegenix, Inc. | Compound as antagonist of lysophosphatidic acid receptor, composition, and use thereof |
| WO2012138648A1 (en) | 2011-04-06 | 2012-10-11 | Irm Llc | Compositions and methods for modulating lpa receptors |
| WO2013070879A1 (en) | 2011-11-10 | 2013-05-16 | Bristol-Myers Squibb Company | Methods for treating spinal cord injury with lpa receptor antagonists |
| US20140329871A1 (en) | 2011-12-04 | 2014-11-06 | Angion Biomedica Corp. | Small molecule anti-fibrotic compounds and uses thereof |
| IN2014DN09352A (https=) | 2012-06-20 | 2015-07-17 | Hoffmann La Roche | |
| SG11201407229UA (en) * | 2012-06-20 | 2014-12-30 | Hoffmann La Roche | Substituted pyrazole compounds as lpar antagonists |
| JP2015520202A (ja) | 2012-06-20 | 2015-07-16 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | Ｌｐａｒ拮抗薬としてのｎ−アルキルトリアゾール化合物 |
| WO2014145873A2 (en) * | 2013-03-15 | 2014-09-18 | Epigen Biosciences, Inc. | Heterocyclic compounds useful in the treatment of disease |
| EP3200588A4 (en) * | 2014-09-17 | 2018-04-25 | Epizyme, Inc. | Arginine methyltransferase inhibitors and uses thereof |
| AR108838A1 (es) * | 2016-06-21 | 2018-10-03 | Bristol Myers Squibb Co | Ácidos de carbamoiloximetil triazol ciclohexilo como antagonistas de lpa |
| CN112041302B (zh) * | 2017-12-19 | 2024-11-19 | 百时美施贵宝公司 | 作为lpa拮抗剂的吡唑o-连接的氨基甲酰基环己基酸 |
| ES2898364T3 (es) * | 2017-12-19 | 2022-03-07 | Bristol Myers Squibb Co | Acidos carbamoilciclohexílicos ligados a N triazol como antagonistas de LPA |
| JP7212047B2 (ja) * | 2017-12-19 | 2023-01-24 | ブリストル－マイヤーズ スクイブ カンパニー | Ｌｐａアンタゴニストとしてのシクロヘキシル酸ピラゾールアゾール |
| WO2019126084A1 (en) * | 2017-12-19 | 2019-06-27 | Bristol-Myers Squibb Company | Isoxazole o-linked carbamoyl cyclohexyl acids as lpa antagonists |
-
2018
- 2018-12-18 EP EP18830676.5A patent/EP3728216B1/en active Active
- 2018-12-18 AU AU2018388482A patent/AU2018388482A1/en not_active Abandoned
- 2018-12-18 JP JP2020533674A patent/JP7301839B2/ja active Active
- 2018-12-18 CA CA3085347A patent/CA3085347A1/en not_active Abandoned
- 2018-12-18 US US16/954,310 patent/US11384067B2/en active Active
- 2018-12-18 WO PCT/US2018/066110 patent/WO2019126085A1/en not_active Ceased
- 2018-12-18 SG SG11202005701VA patent/SG11202005701VA/en unknown
- 2018-12-18 CN CN201880089037.2A patent/CN111699180B/zh active Active
- 2018-12-18 ES ES18830676T patent/ES2962367T3/es active Active
- 2018-12-18 KR KR1020207020528A patent/KR102698386B1/ko active Active
- 2018-12-18 EA EA202091500A patent/EA202091500A1/ru unknown
- 2018-12-18 BR BR112020011953-9A patent/BR112020011953A2/pt not_active Application Discontinuation
- 2018-12-18 MX MX2020005874A patent/MX2020005874A/es unknown
-
2020
- 2020-06-14 IL IL275361A patent/IL275361A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021507895A5 (https=) | ||
| JP2021507896A5 (https=) | ||
| JP2022500470A5 (https=) | ||
| HRP20211918T1 (hr) | Triazol n-vezane karbamoil cikloheksil kiseline kao lpa antagonisti | |
| JP2021508686A5 (https=) | ||
| JP2021506878A5 (https=) | ||
| JP2022500469A5 (https=) | ||
| JP2022500473A5 (https=) | ||
| US10941113B2 (en) | Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis B | |
| JP6824954B2 (ja) | ｍＩＤＨ１阻害剤としての５−ヒドロキシアルキルベンズイミダゾール | |
| JP2019518766A5 (https=) | ||
| JP2021507900A5 (https=) | ||
| JP2021534124A5 (https=) | ||
| JP6824952B2 (ja) | ｍＩＤＨ１阻害剤としての２−アリール−および２−アリールアルキル−ベンズイミダゾール | |
| JP2020183410A5 (https=) | ||
| JP2017511794A5 (https=) | ||
| JP2020507589A5 (https=) | ||
| JP2019521984A5 (https=) | ||
| JP2019530669A5 (https=) | ||
| JP2023544476A5 (https=) | ||
| JP6783756B2 (ja) | ｍＩＤＨ１阻害剤としてのベンゾイミダゾール−２−アミン | |
| JP2017524022A (ja) | Ｊａｋ阻害剤としてのアミノピリミジニル化合物 | |
| JP2010539110A5 (https=) | ||
| JP2005536475A5 (https=) | ||
| JP2017525757A5 (https=) |